We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ARX:TSXARC Resources Ltd. Analysis

Data as of 2026-05-13 - not real-time

CA$30.92

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ARC Resources is trading near the upper end of its 20‑day SMA while remaining above the 50‑day and 200‑day averages, a classic bullish alignment. The RSI sits in the upper half of its range, indicating continued buying momentum, and the MACD line sits above its signal, producing a modest positive histogram. Support around the low‑$24 region remains well‑below the current price, while resistance near $32 is just above today’s level, leaving room for upside. Volatility is elevated, reflecting the recent acquisition announcement, but the stock’s beta is negative, suggesting it may move independently of broader market swings. These technical cues point to a short‑term upside potential.
The fundamentals reinforce a value case: revenue is growing at nearly 20 % year‑over‑year, margins are solid, and free cash flow comfortably covers the modest debt load. A trailing P/E of roughly twelve is well under the industry average, and the dividend yield of about 2.7 % is backed by a payout ratio under one‑third, indicating sustainability. The DCF model places intrinsic value well above the market price, implying an undervalued position. Most importantly, the announced cash‑and‑share acquisition by Shell at a premium to the current price provides a clear catalyst, with the deal price anchored around $32.80 per share. Investors should weigh the near‑term upside from the transaction against the limited long‑term upside once the deal closes.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • acquisition premium priced into the stock
  • bullish technical indicators
  • strong cash flow supporting dividend

Medium Term

1–3 years
Neutral
Model confidence: 8/10

Key Factors

  • integration with Shell providing stability
  • sustained dividend yield
  • valuation still below intrinsic fair value

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • limited upside after deal completion
  • potential for continued dividend income
  • exposure to commodity price volatility

Key Metrics & Analysis

Financial Health

Revenue Growth19.60%
Profit Margin22.74%
P/E Ratio12.2
ROE17.41%
ROA8.75%
Debt/Equity43.61
P/B Ratio2.0
Op. Cash FlowCA$3.1B
Free Cash FlowCA$891.0M
Industry P/E20.9

Technical Analysis

TrendBullish
RSI61.6
SupportCA$24.37
ResistanceCA$32.33
MA 20CA$29.06
MA 50CA$28.12
MA 200CA$26.12
MACDBullish
VolumeDecreasing
Fear & Greed Index89.48

Valuation

Fair ValueCA$40.14
Target PriceCA$33.11
Upside/Downside7.07%
GradeUndervalued
TypeValue
Dividend Yield2.72%

Risk Assessment

Beta-0.50
Volatility66.97%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.